Ultragenyx Pharmaceutical reported a grant under Nasdaq listing rules on June 21, 2025.
1 report, 0 independent
Updated Jun 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ultragenyx Pharmaceutical reported a grant under Nasdaq listing rules on June 21, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ultragenyx Pharmaceutical
biopharmaceutical company based in Novato, California, United States
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Unknown outlet